SCHEMBL23743323

SCHEMBL23743323

OC(c1ccccc1)(c1ccccc1)c1cccc(Cl)c1-c1ccc2ccccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FABP3 P05413 1/20 0.48
▸ FABP4 P15090 1/20 0.48
▸ FABP5 Q01469 1/20 0.48
▸ ABL1 P00519 1/20 0.40
▸ HSD17B1 P14061 2/20 0.38
▸ HSD17B2 P37059 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP3A5 P20815 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ FTO Q9C0B1 1/20 0.38
▸ CYP19A1 P11511 2/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ AKR1C3 P42330 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23743377 0.82 FABP3 (0.47) FABP3FABP4FABP5ABL1HSD17B1
SCHEMBL16384878 0.79 HPGD (0.54) HSD17B1HSD17B2CYP1A2CYP2D6CYP2C9
SCHEMBL23743471 0.76 ESR2 (0.44) FABP3FABP4FABP5ABL1HSD17B1
SCHEMBL30132955 0.74 CYP2A6 (0.44) HSD17B1HSD17B2CYP3A4CYP3A5CYP1A2
SCHEMBL24743383 0.74 CYP2A6 (0.44) HSD17B1HSD17B2CYP3A4CYP3A5CYP1A2
SCHEMBL24329306 0.72 CYP3A4 (0.42) CYP3A4CYP3A5CYP1A2CYP2D6CYP2C9
SCHEMBL30114522 0.72 CYP3A4 (0.60) CYP3A4CYP3A5CYP1A2CYP2D6CYP2C9
SCHEMBL2131459 0.72 CYP3A4 (0.60) CYP3A4CYP3A5CYP1A2CYP2D6CYP2C9
SCHEMBL24371746 0.71 CNR1 (0.40) HSD17B1HSD17B2CYP3A4CYP1A2CYP2D6
SCHEMBL6369696 0.71 CYP3A4 (0.47) CYP3A4CYP3A5CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210249607-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210249607-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 FABP3 1988/4885FABP4 2632/4885FABP5 2518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback